{"gene":"CCL21","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":2000,"finding":"CCL21 (TCA-4/SLC/6Ckine) is constitutively presented on the luminal surface of high endothelial venules (HEVs) in peripheral lymph nodes, where it activates LFA-1 on rolling T cells via CCR7 (a Gαi-linked receptor), triggering firm adhesion; CCL21 delivered via afferent lymph to draining PLNs was sufficient to restore LFA-1-mediated T cell arrest in plt/plt HEVs that lack endogenous CCL21.","method":"Intravital microscopy of murine PLNs with adoptively transferred GFP+ T cells; CCR7 desensitization; intracutaneous injection of CCL21 into plt/plt mice","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — in vivo functional rescue experiment with multiple orthogonal approaches (desensitization, reconstitution, imaging)","pmids":["10620605"],"is_preprint":false},{"year":1998,"finding":"The CC chemokine 6Ckine (CCL21) binds and activates the CXC chemokine receptor CXCR3 in addition to CCR7, inducing calcium flux in CXCR3-transfected cells; CCL21 also displays angiostatic properties similar to other CXCR3 ligands.","method":"Calcium flux assay in mouse CXCR3-transfected cells screened against a panel of chemokines; Matrigel angiostasis assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro receptor binding/activation assay with functional readout","pmids":["9653165"],"is_preprint":false},{"year":1999,"finding":"Mouse 6Ckine (CCL21) is encoded by two distinct genes; one gene expressed in lymphoid organs is deleted in plt/plt mice, explaining the absence of CCL21 in lymphoid tissues of those mice and their T cell homing defect.","method":"Genomic analysis, gene deletion mapping in plt/plt mice","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — direct genetic characterization with functional consequence (loss of lymphoid CCL21 expression)","pmids":["10523616"],"is_preprint":false},{"year":2000,"finding":"Ectopic expression of CCL21 (TCA4/SLC) in pancreatic islets is sufficient to trigger lymphoid neogenesis, recruiting naive T cells and dendritic cells (which express CCR7) and inducing organized lymphoid tissue with high endothelial venules and stromal reticulum; B cell recruitment required T cells/DCs as intermediaries.","method":"Transgenic mouse model with islet-specific CCL21 expression; backcross to RAG-1 and Ikaros knockout mice","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — genetic gain-of-function with defined cellular and structural readouts, replicated in multiple genetic backgrounds","pmids":["10754285"],"is_preprint":false},{"year":2000,"finding":"Mouse CCL21/SLC exerts antitumor effects through two mechanisms: (1) angiostasis via interaction with CXCR3, and (2) induction of CD8+ T cell- and NK cell-mediated tumor-specific immunity; tumor-infiltrating DCs retained an immature phenotype.","method":"Tumor cell transduction with CCL21 cDNA; in vivo Matrigel assay for angiostasis; antibody depletion of CD8+ T cells and NK cells; immunohistochemistry","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal in vivo mechanistic approaches (angiostasis assay, depletion experiments, immunophenotyping)","pmids":["10925282"],"is_preprint":false},{"year":2004,"finding":"CCL21 is involved in recruitment of T-cell precursors to the fetal thymus; neutralizing antibodies against CCL21 (and CCL25) markedly diminish fetal thymus colonization, and CCL21-deficient plt/plt mice show partial defects in this colonization.","method":"Time-lapse visualization culture of fetal thymus colonization; neutralizing antibody blockade; plt/plt mice","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — functional reconstitution assay with antibody neutralization and genetic knockout, replicated with multiple approaches","pmids":["15358618"],"is_preprint":false},{"year":2008,"finding":"Neuronal CCL21 is sorted into large dense-core vesicles (the regulated secretory pathway) and preferentially transported into axons, establishing a mechanism for directed neuron-to-microglia communication from injured neurons.","method":"Live-cell imaging of CCL21-vesicle trafficking; subcellular fractionation; fluorescence microscopy of axonal vs. dendritic sorting","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 — direct live-cell imaging and subcellular fractionation with functional interpretation","pmids":["18697841"],"is_preprint":false},{"year":2011,"finding":"CCL21 expressed in injured primary sensory neurons is transported to central terminals in the dorsal horn, where it up-regulates microglial P2X4 receptor expression to initiate neuropathic pain (tactile allodynia); CCL21-deficient mice do not develop allodynia or upregulate P2X4, and intrathecal CCL21 restores allodynia in CCL21-deficient nerve-injured mice in a P2X4-dependent manner.","method":"CCL21 knockout mice, intrathecal antibody blockade, intrathecal CCL21 injection, in vitro CCL21 application to microglia, P2X4 receptor expression assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function KO with rescue experiment and mechanistic pathway identification (P2X4 dependence)","pmids":["21441897"],"is_preprint":false},{"year":2009,"finding":"CCL21 costimulates CD4+ T cell activation via CCR7 through a DOCK2/Rac-dependent pathway: CCL21 during early TCR signaling increases Ras- and Rac-GTP formation, phosphorylation of Akt, MEK, and ERK (but not p38 or JNK), lowering the T cell activation threshold; DOCK2 deficiency impairs CCL21 costimulation and Rac-GTP formation.","method":"Primary TCR-transgenic CD4+ T cells; kinase-dead PI3Kδ and PI3Kγ-deficient mice; DOCK2-deficient mice; GTPase activation assays; lymph node slice live imaging","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic KO models with biochemical pathway dissection","pmids":["19451552"],"is_preprint":false},{"year":2010,"finding":"CCR7/CCL21-mediated T lymphocyte migration on fibronectin requires rapid, transient ERK1/2 phosphorylation (within 2 min) downstream of PLCγ1; PLCγ1 shRNA knockdown reduces ERK1/2 phosphorylation and CCR7-mediated migration, and ERK1/2 inhibition reduces PLCγ1 phosphorylation, indicating a feedback loop between ERK1/2 and PLCγ1.","method":"shRNA knockdown of PLCγ1; pharmacological inhibition of MEK (U0126) and PLC (U73122); phosphorylation assays; migration assays on fibronectin","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches (genetic KD + pharmacological inhibition) with defined signaling pathway","pmids":["20889506"],"is_preprint":false},{"year":2010,"finding":"CCL21 alone (without CCL19) is sufficient to mediate DC migration from skin, DC maturation, and efficient T cell priming in vivo; CCL19 is redundant for these processes, as demonstrated in CCL19-deficient mice expressing various levels of CCL21.","method":"CCL19-deficient mice with varying CCL21 expression levels; flow cytometry of DC frequencies and localization; T cell priming assays","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with dose-response analysis across multiple CCL21 levels","pmids":["20201039"],"is_preprint":false},{"year":2019,"finding":"GPR174, an X-chromosome-encoded GPCR, is identified as a receptor for CCL21; CCL21 triggers GPR174-mediated calcium flux and preferentially induces migration of male B cells; GPR174 associates more strongly with Gαi protein in male than female B cells, and this sex difference is regulated by testosterone.","method":"Biochemical fractionation of conditioned media; calcium flux assay; B cell migration assay; Co-IP of GPR174-Gαi; orchidectomy and testosterone treatment; GPR174 conditional deletion","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — biochemical identification of CCL21 as GPR174 ligand with functional validation (calcium flux, migration), multiple orthogonal methods including genetic deletion and hormonal manipulation","pmids":["31875850"],"is_preprint":false},{"year":2021,"finding":"ACKR4 scavenges two forms of CCL21 in barrier tissues — full-length immobilized and cleaved soluble CCL21 — to establish functional extracellular CCL21 gradients; without ACKR4, CCL21 gradients are saturated and non-functional, DCs cannot home to lymphatic vessels, and excess soluble CCL21 from peripheral tissues floods downstream lymph nodes.","method":"ACKR4-deficient mice; quantification of CCL21 forms in skin and LNs; DC migration assays; flow cytometry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with biochemical characterization of two CCL21 forms and mechanistic explanation of gradient regulation","pmids":["33875601"],"is_preprint":false},{"year":2002,"finding":"Low-molecular-weight heparins (and glycosaminoglycans) strongly inhibit CCL21-induced T cell adhesion and chemotaxis; enzymatic cleavage of GAGs abrogates this inhibition, revealing that heparin-like GAGs regulate CCL21 function by modulating its local availability.","method":"T cell adhesion and chemotaxis assays with heparinase treatment and low-molecular-weight heparins","journal":"The Journal of pharmacology and experimental therapeutics","confidence":"Medium","confidence_rationale":"Tier 2 — direct in vitro functional assays with enzymatic and pharmacological tools; single lab","pmids":["12065729"],"is_preprint":false},{"year":2002,"finding":"CCL21 expression is induced in endothelial cells during T cell autoimmune skin diseases, where its receptor CCR7 is expressed on infiltrating memory T cells (CD45Ro+), suggesting a role for CCL21/CCR7 in mediating T cell infiltration at sites of autoimmune inflammation.","method":"Immunohistology of T-cell autoimmune skin disease specimens","journal":"Blood","confidence":"Low","confidence_rationale":"Tier 3 — immunohistology only, no functional experiment","pmids":["12393410"],"is_preprint":false},{"year":2003,"finding":"CCL21 activates CCR7 on hepatic stellate cells (HSCs), triggering ERK, Akt, and NF-κB signaling pathways, stimulating HSC migration and wound healing in vitro, and inducing pro-inflammatory gene expression, implicating CCL21/CCR7 in hepatic fibrogenesis.","method":"In vitro HSC migration assay; wound healing assay; Western blot for ERK, Akt, NF-κB; CCR7 expression by flow cytometry","journal":"Gastroenterology","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro functional assays with multiple signaling pathway readouts; single lab","pmids":["14517790"],"is_preprint":false},{"year":2004,"finding":"CCL21 (SLC/CCL21) binding to CCR7 on human mesangial cells enhances their adhesion to fibronectin in a time- and concentration-dependent manner, activates integrin-linked kinase (ILK) leading to phosphorylation of GSK-3 and PKB/Akt, and causes F-actin rearrangements with membrane ruffling.","method":"Adhesion assays; mechanical detachment assays; ILK activity assay; phalloidin immunofluorescence for F-actin","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays with defined signaling readouts; single lab","pmids":["15569314"],"is_preprint":false},{"year":2006,"finding":"CCL21/CCR7 signaling promotes the migration of CCR7+ fibrocytes into the kidney in response to CCL21+ vessels during renal fibrosis; blockade of CCL21/CCR7 (anti-CCL21 antibodies or CCR7-null mice) reduced fibrocyte infiltration, renal fibrosis, TGF-β1 and collagen I transcripts, and macrophage recruitment.","method":"Unilateral ureteral obstruction mouse model; anti-CCL21 antibody blockade; CCR7-null mice; immunohistochemistry; qRT-PCR","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — both pharmacological neutralization and genetic knockout with consistent phenotype; replicated across two approaches","pmids":["16966615"],"is_preprint":false},{"year":2009,"finding":"CCR7-CCL19/CCL21 pathway is required for antigen-bearing dendritic cells to migrate from sublingual mucosa to cervical lymph nodes and prime antigen-specific T and B cell responses; depletion of CD11c+ cells or CCR7 deficiency abolished T cell proliferation after sublingual vaccination.","method":"CCR7-/- mice; CD11c depletion; reconstitution with OVA-specific CD4+/CD8+ T cells; flow cytometry; antibody measurement","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — genetic KO and cell depletion with defined functional readouts","pmids":["19454681"],"is_preprint":false},{"year":2012,"finding":"CCL21 (but not CCL19) induces human microvascular endothelial cell (HMVEC) migration and tube formation via CCR7 through the PI3K pathway; CCL21 promotes blood vessel growth in Matrigel plugs in vivo at concentrations found in RA joints, identifying CCL21 as a direct mediator of angiogenesis.","method":"HMVEC chemotaxis assays; tube formation assays; PI3K/ERK/JNK pathway inhibitors; in vivo Matrigel plug assay; CCR7 neutralization","journal":"Arthritis and rheumatism","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro assays plus in vivo Matrigel with receptor neutralization and pathway inhibition","pmids":["22392503"],"is_preprint":false},{"year":2012,"finding":"CCL21/CCR7 activation prevents apoptosis in non-small cell lung cancer cells by upregulating Bcl-2 and downregulating Bax and caspase-3 via the ERK pathway; co-immunoprecipitation confirmed interaction between p-ERK and Bcl-2/Bax/caspase-3.","method":"Flow cytometry apoptosis assay; Western blot and qRT-PCR; MEK inhibitor PD98059; CCR7 siRNA knockdown; co-immunoprecipitation","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KD + pharmacological inhibition + Co-IP with defined pathway; single lab","pmids":["22438908"],"is_preprint":false},{"year":2015,"finding":"CCL21/CCR7 axis promotes breast cancer-associated lymphangiogenesis by upregulating VEGF-C secretion via AKT signaling; in vivo, CCR7/CCL21-expressing breast cancer cells promote lymph-vascular recruitment; in vitro, CCL21/CCR7 drives LEC proliferation, migration, and tube formation.","method":"In vivo orthotopic nude mouse model with CCR7/CCL21 gene-manipulated cells; in vitro LEC functional assays; Western blot for AKT; qRT-PCR; IHC","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo genetic manipulation plus in vitro mechanistic assays; single lab","pmids":["25744065"],"is_preprint":false},{"year":2018,"finding":"Formation of intrathymic dendritic cell type 1 (cDC1) pool requires CCR7-CCL21Ser interactions to guide migration of CCR7+ cDC progenitors to the thymus; mice lacking CCR7 or CCL21Ser (but not CCL19) show selective reduction in thymic cDC1.","method":"CCR7-/-, CCL21Ser-/-, and CCL19-/- mice; flow cytometry of thymic DC subsets; progenitor identification","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic KO models with ligand-specific dissection of requirements","pmids":["29784760"],"is_preprint":false},{"year":2021,"finding":"CCL21 neonatal thymus emigration is mediated by CCL21 (not CCL19); CCL21 gene expression occurs in medullary epithelial subsets while CCL21 protein is captured and presented at sites of thymic exit by integrin α7+ pericytes and CD34+ adventitial cells via heparan sulfate-dependent interaction with CCL21's C-terminal extension; CCL19 (which lacks this domain) is not captured by thymic stroma.","method":"CCL21- and CCL19-deficient mice; Ccl21 gene expression mapping; CCL21 protein distribution analysis; cell-type fractionation; heparan sulfate dependency assays","journal":"Blood advances","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with mechanistic dissection of protein capture via C-terminal domain and heparan sulfate; orthogonal approaches","pmids":["33570638"],"is_preprint":false},{"year":2017,"finding":"CCR7 sulfotyrosine (sY) at positions Y8 and Y17 enhances CCL21 binding affinity; sY8-containing peptides bind near the CCL21 α-helix while sY17-containing peptides bind near the N-loop and β3-strand; phosphotyrosine also enhances binding but less than sulfotyrosine.","method":"Protein NMR spectroscopy of CCL21 with CCR7 N-terminal peptides containing Tyr, phosphoTyr, or sulfoTyr","journal":"International journal of molecular sciences","confidence":"High","confidence_rationale":"Tier 1 — structural NMR with defined binding site mapping","pmids":["28841151"],"is_preprint":false},{"year":2018,"finding":"Fluorescently tagged CCL21-mRFP retains functional activity and can be used to visualize and quantify CCL21 gradients in real time; CCL21-mRFP is internalized by CCR7-expressing cells and scavenged by ACKR4, enabling spatiotemporal study of receptor trafficking and chemokine gradient formation.","method":"Fusion protein production; receptor trafficking assays; chemokine scavenging assays; live-cell gradient visualization","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 — functional validation of tagged chemokine with receptor trafficking and scavenging readouts; single lab","pmids":["30518137"],"is_preprint":false},{"year":2018,"finding":"CCL21's C-terminal extension mediates its enhanced binding to glycosaminoglycans (GAGs) on dendritic cell surfaces; transfer of CCL21-tail to CCL19 increases GAG binding but negatively affects cAMP signaling potency; removal of CCL21 tail (CCL21tailless) increases cAMP signaling compared to full-length CCL21, indicating the C-terminal tail autoinhibits CCR7 signaling.","method":"CCL21/CCL19 chimeric proteins; calcium release assays; cAMP assays in CHO cells; DC chemotaxis assays; CCR7 internalization assays","journal":"Journal of leukocyte biology","confidence":"High","confidence_rationale":"Tier 1 — domain-swap mutagenesis with multiple functional readouts (GAG binding, cAMP, calcium, chemotaxis, receptor internalization)","pmids":["29768676"],"is_preprint":false},{"year":2020,"finding":"CCL21 promotes migration of pancreatic cancer cells toward sensory neurons via CCR7 expressed on cancer cells; neutralization of CCL21 or CCR7 in mice with orthotopic tumors reduces nociceptive hypersensitivity and nerve fiber hypertrophy without affecting tumor immune infiltration.","method":"RNA interference screen; PDAC cell migration assays; neutralizing antibody treatment in orthotopic tumor model; abdominal mechanical hypersensitivity testing; histology","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 — unbiased RNAi screen followed by functional validation in vivo with neutralizing antibodies; multiple readouts","pmids":["32330476"],"is_preprint":false},{"year":2020,"finding":"CCL21/CCR7 interaction activates JAK2/STAT3 signaling in oral squamous cell carcinoma cells, promoting EMT and cancer stem cell properties (CD133, CD44, BMI1, ALDH1A1, OCT4 upregulation); JAK2/STAT3 inhibition suppresses these CCL21-induced effects.","method":"Exogenous CCL21 stimulation; CCR7 knockdown and overexpression; JAK2/STAT3 inhibitor treatment; Western blot; migration/invasion/tumorsphere assays","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic manipulation plus pharmacological inhibition with pathway identification; single lab","pmids":["32017846"],"is_preprint":false},{"year":2009,"finding":"CCL21 induces calcium transients in primary mouse astrocytes via CXCR3 at low concentrations; at high CCL21 concentrations (10⁻⁷ M), calcium transients persist in CXCR3-deficient astrocytes, and CCL21-induced proliferation is not impaired in CXCR3-deficient astrocytes, indicating CCL21 activates an additional, as-yet unidentified receptor on astrocytes.","method":"Calcium imaging; CXCR3-deficient astrocytes; CXCL10 comparison; proliferation assays","journal":"Brain, behavior, and immunity","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with pharmacological comparison; identifies additional receptor but does not identify it","pmids":["19401230"],"is_preprint":false},{"year":2006,"finding":"CCL21/CCL19 produced in secondary lymphoid organs promote activation-induced cell death (AICD) of antigen-responding CD4+ T cells during the clonal contraction phase, partly by enhancing Fas ligand expression; plt/plt mice lacking CCL21/CCL19 show prolonged CD4+ T cell responses without increased apoptosis.","method":"plt/plt mice immunized with OVA/CFA; in vivo tracking of OVA-responding CD4+ T cells; in vitro AICD assay with CCL19/CCL21; Fas ligand expression analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with in vitro mechanistic follow-up (FasL expression); consistent in vivo and in vitro results","pmids":["16973962"],"is_preprint":false},{"year":2011,"finding":"ZAP-70 expression in CLL B cells enhances CCR7 upregulation after IgM stimulation via the ERK1/2 (MAPK) pathway, increasing CCR7 signaling and migration toward CCL21; ERK1/2 inhibition impairs CCR7 upregulation and CCL21-directed migration.","method":"ZAP-70-transfected Ramos cell line; ERK1/2, Akt, Syk phosphorylation assays; CCR7 expression by flow cytometry; migration assay toward CCL21; primary CLL samples","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — stable transfection with pathway inhibition; validated in primary CLL samples","pmids":["21865343"],"is_preprint":false},{"year":2015,"finding":"CCL21-CCR7 promotes lymph node metastasis of esophageal squamous cell carcinoma by upregulating MUC1 via ERK1/2-mediated phosphorylation of Sp1, which increases Sp1 binding to the MUC1 promoter at -99/-90; Akt is also activated but is not responsible for MUC1 transcriptional upregulation.","method":"Transwell migration/invasion assays; luciferase reporter assay; Western blot for ERK, Akt, Sp1; ChIP for Sp1 binding to MUC1 promoter; MUC1 knockdown","journal":"Journal of experimental & clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple mechanistic assays including ChIP; single lab","pmids":["26667143"],"is_preprint":false},{"year":2015,"finding":"CCL21 facilitates chemoresistance and cancer stem cell properties in colorectal cancer via the AKT/GSK-3β/Snail signaling pathway, upregulating P-glycoprotein and stem cell markers (Bmi-1, Nanog, OCT-4) at the post-transcriptional level; PI3K/Akt inhibitor (LY294002) abolishes these effects.","method":"CCL21 treatment of HCT116 cells; Western blot; PI3K inhibitor LY294002; mammosphere formation assay; cell survival assay","journal":"Oxidative medicine and cellular longevity","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological inhibition with multiple readouts; single lab","pmids":["27057280"],"is_preprint":false},{"year":2013,"finding":"CCL21 (via CCR7/CCL21 axis, assessed in plt/plt mice) is required for nerve injury-evoked tactile allodynia but not autoimmunity-evoked (EAE) hyperalgesia; conversely, CXCR3 mediates EAE-evoked hyperalgesia but not traumatic nerve injury pain, demonstrating dichotomous roles for CCL21 ligands in different neuropathic pain contexts.","method":"plt/plt mice; CXCR3-/- mice; double knockout mice; sciatic nerve injury; EAE model; behavioral pain testing; spinal cord immunophenotyping","journal":"Brain, behavior, and immunity","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic KO models with epistasis analysis; two distinct pain models","pmids":["23643685"],"is_preprint":false},{"year":2020,"finding":"ACKR4 on non-hematopoietic cells controls intratumoral CCL21 abundance, which in turn regulates CD103+ dendritic cell retention in tumors and CD8+ T cell accumulation; in the absence of ACKR4, increased intratumoral CCL21 promotes anti-tumor immunity and inhibits tumor growth.","method":"ACKR4-deficient mice; bone marrow chimeras to define non-hematopoietic ACKR4 requirement; flow cytometry of tumor-infiltrating leukocytes; CCL21 quantification in tumors","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with bone marrow chimeras defining cell-specific mechanism; CCL21 quantification","pmids":["32289156"],"is_preprint":false},{"year":2023,"finding":"In severe COVID-19, CCL21 overexpression in activated adventitial niches is associated with endothelial-to-mesenchymal transition and tissue fibrosis, and links to accumulation of CCR7-expressing exhausted T cells that form lymphoid aggregates and ectopic lymphoid structures.","method":"Advanced imaging; spatial transcriptomics of COVID-19 lung tissue; immunophenotyping","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 3 — spatial transcriptomics and imaging without functional manipulation; association between CCL21 and cellular/structural outcomes","pmids":["36774347"],"is_preprint":false}],"current_model":"CCL21 is a constitutively expressed CC chemokine that primarily signals through CCR7 (and also CXCR3 and GPR174) to orchestrate the migration and positioning of naïve T cells, dendritic cells, and NK cells in secondary lymphoid organs via LFA-1 activation and DOCK2/Rac-ERK-dependent pathways; in the nervous system, CCL21 is expressed in injured neurons, packaged into large dense-core vesicles, and transported axonally to the dorsal horn where it upregulates microglial P2X4 receptor expression to initiate neuropathic pain; its C-terminal extension mediates heparan sulfate/GAG-dependent immobilization and gradient formation, which is regulated by ACKR4-mediated scavenging, and CCL21 additionally drives angiogenesis, fibrosis, lymphoid neogenesis, and cancer cell migration via PI3K/AKT, JAK2/STAT3, and ERK signaling cascades downstream of CCR7."},"narrative":{"teleology":[{"year":1998,"claim":"Establishing that CCL21 signals through a second receptor (CXCR3) in addition to its primary receptor CCR7 expanded its functional repertoire to include angiostatic activity shared with CXC chemokines.","evidence":"Calcium flux assay in CXCR3-transfected cells plus Matrigel angiostasis assay","pmids":["9653165"],"confidence":"High","gaps":["Whether CXCR3-mediated angiostasis is relevant in vivo in tumor microenvironments was not resolved","Relative contribution of CXCR3 vs. CCR7 signaling in different cell types unclear"]},{"year":1999,"claim":"Identification of two distinct CCL21 genes in mice, with one deleted in plt/plt mice, provided the genetic basis for the T cell homing defect and established plt/plt as a bona fide CCL21-deficiency model.","evidence":"Genomic deletion mapping in plt/plt mice","pmids":["10523616"],"confidence":"High","gaps":["Functional difference between the two mouse CCL21 gene products not fully defined","Whether human CCL21 gene regulation parallels the two-gene system was unresolved"]},{"year":2000,"claim":"CCL21 was shown to be the critical chemokine presented on HEV luminal surfaces that triggers LFA-1-mediated T cell arrest via CCR7/Gαi signaling, and its ectopic expression sufficed to drive lymphoid neogenesis with organized HEVs and stromal reticulum.","evidence":"Intravital microscopy with CCR7 desensitization and plt/plt reconstitution; transgenic islet-specific CCL21 expression in RAG-1 and Ikaros KO backgrounds; tumor transduction with CCL21 cDNA plus antibody depletion experiments","pmids":["10620605","10754285","10925282"],"confidence":"High","gaps":["Mechanism by which CCL21 induces HEV differentiation and stromal remodeling not defined","Relative roles of CCL21 vs. CCL19 in lymphoid neogenesis unresolved"]},{"year":2002,"claim":"Demonstrating that glycosaminoglycans regulate CCL21 bioavailability by modulating its local concentration established the importance of GAG interactions for CCL21 gradient function.","evidence":"T cell adhesion and chemotaxis assays with heparinase treatment and low-molecular-weight heparins","pmids":["12065729"],"confidence":"Medium","gaps":["Specific GAG structures involved not identified","In vivo relevance of GAG-mediated CCL21 regulation not demonstrated at this stage"]},{"year":2004,"claim":"CCL21 was shown to participate in fetal thymus colonization by T cell precursors, extending its role from peripheral lymphoid homing to thymic seeding.","evidence":"Time-lapse fetal thymus colonization assay with anti-CCL21 neutralization and plt/plt mice","pmids":["15358618"],"confidence":"High","gaps":["Relative contribution of CCL21 vs. CCL25 in thymic colonization not fully dissected","Whether CCL21 acts as a chemoattractant or a retention signal for thymic progenitors was unclear"]},{"year":2006,"claim":"Two new functional dimensions of CCL21 were established: promotion of renal fibrosis via CCR7+ fibrocyte recruitment, and regulation of T cell clonal contraction through enhancement of Fas ligand-mediated AICD.","evidence":"Ureteral obstruction model with anti-CCL21 antibody and CCR7-null mice; plt/plt mice immunized with OVA/CFA with in vitro AICD assays","pmids":["16966615","16973962"],"confidence":"High","gaps":["Whether CCL21 directly upregulates FasL on T cells or acts indirectly through DCs not resolved","Contribution of CCL21 vs. CCL19 to AICD not fully separated"]},{"year":2008,"claim":"Discovery that neuronal CCL21 is sorted into large dense-core vesicles and preferentially transported into axons established a mechanism for directed neuron-to-microglia signaling distinct from its immunological roles.","evidence":"Live-cell imaging of CCL21-vesicle trafficking with subcellular fractionation in primary neurons","pmids":["18697841"],"confidence":"High","gaps":["The receptor on microglia mediating CCL21 responses in the CNS was not identified at this point","Stimulus for neuronal CCL21 transcriptional induction after injury was unknown"]},{"year":2009,"claim":"The intracellular signaling cascade downstream of CCR7/CCL21 in T cells was mapped: DOCK2/Rac activation feeds into ERK/MEK phosphorylation to costimulate TCR signaling, while PLCγ1 and ERK1/2 form a positive feedback loop required for T cell migration on fibronectin.","evidence":"DOCK2-deficient, PI3Kδ kinase-dead, and PI3Kγ-deficient primary T cells with GTPase activation assays; PLCγ1 shRNA knockdown with MEK inhibitor treatment in migration assays","pmids":["19451552","20889506"],"confidence":"High","gaps":["How DOCK2 is recruited to the CCR7 signaling complex was not defined","Whether the PLCγ1-ERK feedback loop operates in all CCR7-expressing cell types was untested"]},{"year":2010,"claim":"CCL21 alone was shown to be sufficient for DC migration from skin, DC maturation, and T cell priming, establishing CCL19 as functionally redundant for these processes.","evidence":"CCL19-deficient mice with varying CCL21 expression levels; DC frequency and T cell priming assays","pmids":["20201039"],"confidence":"High","gaps":["Whether CCL19 has non-redundant roles in other contexts (e.g., T cell zone positioning) remained open","Dose-response relationship for CCL21 in sustaining immune homeostasis not defined"]},{"year":2011,"claim":"The neuronal CCL21 pathway was completed: CCL21 transported to dorsal horn central terminals upregulates microglial P2X4 receptors to initiate neuropathic pain, as CCL21 knockout prevents allodynia and intrathecal CCL21 rescues it in a P2X4-dependent manner.","evidence":"CCL21 knockout mice with nerve injury; intrathecal CCL21 injection rescue; P2X4 expression assays on microglia","pmids":["21441897"],"confidence":"High","gaps":["The microglial receptor for CCL21 in the CNS that triggers P2X4 upregulation was not identified (neither CCR7 nor CXCR3 was confirmed)","Whether CCL21 acts directly on microglia or through an intermediate cell type was not definitively established"]},{"year":2013,"claim":"CCL21 was shown to be specifically required for nerve injury-evoked but not autoimmune-evoked neuropathic pain, while CXCR3 mediates the latter, demonstrating context-dependent dichotomy among CCL21's receptor pathways in pain.","evidence":"plt/plt mice, CXCR3-/- mice, and double knockouts tested in sciatic nerve injury vs. EAE models with behavioral pain testing","pmids":["23643685"],"confidence":"High","gaps":["Mechanism distinguishing traumatic vs. autoimmune pain pathways downstream of CCL21 undefined","Whether CXCR3 contributes to CCL21-mediated nerve injury pain was not excluded"]},{"year":2017,"claim":"Structural NMR revealed that CCR7 sulfotyrosine modifications at Y8 and Y17 enhance CCL21 binding by engaging distinct epitopes near the α-helix and N-loop/β3-strand, providing the first atomic-level view of the CCL21-CCR7 interaction.","evidence":"Protein NMR with CCR7 N-terminal peptides containing Tyr, phosphoTyr, or sulfoTyr modifications","pmids":["28841151"],"confidence":"High","gaps":["Full-length CCR7 structure in complex with CCL21 not available","Functional consequences of sulfotyrosine modifications on CCR7 signaling in cells not tested"]},{"year":2018,"claim":"Domain-swap mutagenesis established that CCL21's C-terminal extension autoinhibits CCR7 cAMP signaling while enhancing GAG binding, explaining how immobilized CCL21 creates haptotactic gradients with attenuated receptor activation; separately, CCL21-Ser was shown to specifically guide cDC1 progenitor migration to the thymus.","evidence":"CCL21/CCL19 chimeric proteins with calcium, cAMP, chemotaxis, and receptor internalization assays; CCR7-/-, CCL21Ser-/-, CCL19-/- mice with thymic DC subset analysis","pmids":["29768676","29784760"],"confidence":"High","gaps":["Structural basis for C-terminal tail autoinhibition not resolved","Whether proteolytic removal of the tail is regulated in specific physiological contexts was not tested"]},{"year":2019,"claim":"GPR174 was identified as a third receptor for CCL21, mediating sex-biased B cell migration through testosterone-regulated Gαi coupling, revealing an unexpected layer of CCL21 signaling beyond CCR7 and CXCR3.","evidence":"Biochemical fractionation identifying CCL21 as GPR174 ligand; calcium flux; B cell migration; GPR174 conditional deletion; orchidectomy and testosterone treatment","pmids":["31875850"],"confidence":"High","gaps":["Physiological relevance of GPR174/CCL21 axis in lymphoid organ homeostasis not fully characterized","Whether GPR174 and CCR7 compete for CCL21 or transduce distinct signals on the same cell was unexplored"]},{"year":2020,"claim":"Two studies established CCL21 as a functionally bidirectional signal in tumors: ACKR4 scavenging on non-hematopoietic cells limits intratumoral CCL21, restricting CD103+ DC retention and anti-tumor immunity, while CCL21/CCR7 on pancreatic cancer cells promotes perineural invasion and pain.","evidence":"ACKR4-deficient mice with bone marrow chimeras and tumor-infiltrating leukocyte analysis; RNAi screen with orthotopic PDAC model and CCL21/CCR7 neutralization","pmids":["32289156","32330476"],"confidence":"High","gaps":["Whether therapeutic CCL21 augmentation in tumors would enhance immunotherapy efficacy was not tested","Mechanism by which CCL21 promotes nerve fiber hypertrophy in PDAC unknown"]},{"year":2021,"claim":"The CCL21 gradient-shaping mechanism was defined: ACKR4 scavenges both immobilized and cleaved soluble CCL21 forms, while heparan sulfate on pericytes and adventitial cells captures full-length CCL21 via its C-terminal extension, creating functional gradients for DC and thymocyte migration.","evidence":"ACKR4-deficient mice with quantification of two CCL21 forms; CCL21/CCL19-deficient mice with cell-type fractionation and heparan sulfate dependency assays in thymus","pmids":["33875601","33570638"],"confidence":"High","gaps":["Whether specific heparan sulfate sulfation patterns determine CCL21 capture efficiency is unknown","Dynamics of CCL21 cleavage (protease identity, regulation) not defined"]},{"year":null,"claim":"The microglial receptor through which CCL21 upregulates P2X4 in the CNS remains unidentified, the structural basis of the CCL21 C-terminal tail autoinhibition is unresolved, and the functional interplay among CCR7, CXCR3, and GPR174 on cells co-expressing these receptors has not been dissected.","evidence":"","pmids":[],"confidence":"Medium","gaps":["CNS receptor for CCL21 on microglia not identified","No full-length CCR7-CCL21 co-structure available","Signaling crosstalk between CCR7, CXCR3, and GPR174 on co-expressing cells uncharacterized","Protease responsible for C-terminal tail cleavage generating soluble CCL21 not identified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,1,3,11]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[13,23,26]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,12,23]},{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[13,23]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,3,4,5,10,18,30,35]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8,9,15,16,28]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[6,7,34]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[5,22,23]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[20,21,27,28,32,33]}],"complexes":[],"partners":["CCR7","CXCR3","GPR174","ACKR4","LFA-1","DOCK2"],"other_free_text":[]},"mechanistic_narrative":"CCL21 is a constitutively expressed CC chemokine that serves as the principal ligand for CCR7 in organizing immune cell trafficking, lymphoid tissue architecture, and neuroimmune communication. Through CCR7, CCL21 activates LFA-1 on rolling T cells to trigger firm adhesion at high endothelial venules, costimulates CD4+ T cell activation via DOCK2/Rac-ERK signaling, promotes dendritic cell migration from peripheral tissues to draining lymph nodes, and drives activation-induced cell death during clonal contraction [PMID:10620605, PMID:19451552, PMID:20201039, PMID:16973962]. CCL21 also signals through CXCR3 to exert angiostatic effects and through GPR174 to regulate sex-biased B cell migration, while its unique C-terminal extension mediates heparan sulfate-dependent immobilization on stromal cells to form functional chemokine gradients shaped by ACKR4-mediated scavenging [PMID:9653165, PMID:31875850, PMID:29768676, PMID:33875601, PMID:33570638]. In the nervous system, neuronal CCL21 is sorted into large dense-core vesicles, transported axonally to the spinal dorsal horn, and upregulates microglial P2X4 receptors to initiate neuropathic pain after nerve injury [PMID:18697841, PMID:21441897]."},"prefetch_data":{"uniprot":{"accession":"O00585","full_name":"C-C motif chemokine 21","aliases":["6Ckine","Beta-chemokine exodus-2","Secondary lymphoid-tissue chemokine","SLC","Small-inducible cytokine A21"],"length_aa":134,"mass_kda":14.6,"function":"Inhibits hemopoiesis and stimulates chemotaxis. Chemotactic in vitro for thymocytes and activated T-cells, but not for B-cells, macrophages, or neutrophils. Shows preferential activity towards naive T-cells. May play a role in mediating homing of lymphocytes to secondary lymphoid organs. Binds to atypical chemokine receptor ACKR4 and mediates the recruitment of beta-arrestin (ARRB1/2) to ACKR4","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/O00585/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CCL21","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CCL21","total_profiled":1310},"omim":[{"mim_id":"607020","title":"RAS ASSOCIATION DOMAIN FAMILY PROTEIN 5; RASSF5","url":"https://www.omim.org/entry/607020"},{"mim_id":"606065","title":"ATYPICAL CHEMOKINE RECEPTOR 4; ACKR4","url":"https://www.omim.org/entry/606065"},{"mim_id":"605149","title":"CHEMOKINE, CXC MOTIF, LIGAND 13; CXCL13","url":"https://www.omim.org/entry/605149"},{"mim_id":"604520","title":"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 14; TNFSF14","url":"https://www.omim.org/entry/604520"},{"mim_id":"603030","title":"TOLL-LIKE RECEPTOR 4; TLR4","url":"https://www.omim.org/entry/603030"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":2551.0}],"url":"https://www.proteinatlas.org/search/CCL21"},"hgnc":{"alias_symbol":["SLC","exodus-2","TCA4","CKb9","6Ckine","ECL"],"prev_symbol":["SCYA21"]},"alphafold":{"accession":"O00585","domains":[{"cath_id":"2.40.50.40","chopping":"32-95","consensus_level":"medium","plddt":87.6963,"start":32,"end":95}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O00585","model_url":"https://alphafold.ebi.ac.uk/files/AF-O00585-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O00585-F1-predicted_aligned_error_v6.png","plddt_mean":72.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CCL21","jax_strain_url":"https://www.jax.org/strain/search?query=CCL21"},"sequence":{"accession":"O00585","fasta_url":"https://rest.uniprot.org/uniprotkb/O00585.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O00585/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O00585"}},"corpus_meta":[{"pmid":"23506860","id":"PMC_23506860","title":"The ABCs of membrane transporters in health and disease (SLC series): introduction.","date":"2013","source":"Molecular aspects of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23506860","citation_count":452,"is_preprint":false},{"pmid":"10421367","id":"PMC_10421367","title":"Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10421367","citation_count":418,"is_preprint":false},{"pmid":"10620605","id":"PMC_10620605","title":"The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules.","date":"2000","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10620605","citation_count":304,"is_preprint":false},{"pmid":"30464343","id":"PMC_30464343","title":"Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/30464343","citation_count":295,"is_preprint":false},{"pmid":"19164095","id":"PMC_19164095","title":"Analysis and update of the human solute carrier (SLC) gene superfamily.","date":"2009","source":"Human genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19164095","citation_count":250,"is_preprint":false},{"pmid":"23587803","id":"PMC_23587803","title":"A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system.","date":"2013","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/23587803","citation_count":237,"is_preprint":false},{"pmid":"16966615","id":"PMC_16966615","title":"Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16966615","citation_count":223,"is_preprint":false},{"pmid":"15832291","id":"PMC_15832291","title":"Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis.","date":"2005","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15832291","citation_count":205,"is_preprint":false},{"pmid":"15934082","id":"PMC_15934082","title":"Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome.","date":"2005","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/15934082","citation_count":197,"is_preprint":false},{"pmid":"9653165","id":"PMC_9653165","title":"The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9653165","citation_count":181,"is_preprint":false},{"pmid":"30239845","id":"PMC_30239845","title":"The SLC transporter in nutrient and metabolic sensing, regulation, and drug development.","date":"2019","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30239845","citation_count":172,"is_preprint":false},{"pmid":"10523616","id":"PMC_10523616","title":"The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes.","date":"1999","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10523616","citation_count":159,"is_preprint":false},{"pmid":"27672436","id":"PMC_27672436","title":"SLC Transporters: Structure, Function, and Drug Discovery.","date":"2016","source":"MedChemComm","url":"https://pubmed.ncbi.nlm.nih.gov/27672436","citation_count":152,"is_preprint":false},{"pmid":"15073111","id":"PMC_15073111","title":"CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.","date":"2004","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/15073111","citation_count":150,"is_preprint":false},{"pmid":"10441476","id":"PMC_10441476","title":"Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10441476","citation_count":145,"is_preprint":false},{"pmid":"32816947","id":"PMC_32816947","title":"Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion.","date":"2020","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/32816947","citation_count":144,"is_preprint":false},{"pmid":"10754285","id":"PMC_10754285","title":"Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10754285","citation_count":139,"is_preprint":false},{"pmid":"21441897","id":"PMC_21441897","title":"Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21441897","citation_count":139,"is_preprint":false},{"pmid":"21225692","id":"PMC_21225692","title":"Characterization of CCL19 and CCL21 in rheumatoid arthritis.","date":"2011","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/21225692","citation_count":124,"is_preprint":false},{"pmid":"32330476","id":"PMC_32330476","title":"CXCL10 and CCL21 Promote Migration of Pancreatic Cancer Cells Toward Sensory Neurons and Neural Remodeling in Tumors in Mice, Associated With Pain in Patients.","date":"2020","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/32330476","citation_count":120,"is_preprint":false},{"pmid":"10925282","id":"PMC_10925282","title":"Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10925282","citation_count":119,"is_preprint":false},{"pmid":"14517790","id":"PMC_14517790","title":"The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C.","date":"2003","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/14517790","citation_count":116,"is_preprint":false},{"pmid":"25744065","id":"PMC_25744065","title":"The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.","date":"2015","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25744065","citation_count":115,"is_preprint":false},{"pmid":"15358618","id":"PMC_15358618","title":"The role of CCL21 in recruitment of T-precursor cells to fetal thymi.","date":"2004","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15358618","citation_count":112,"is_preprint":false},{"pmid":"32329299","id":"PMC_32329299","title":"The Role of the SLC Transporters Protein in the Neurodegenerative Disorders.","date":"2020","source":"Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32329299","citation_count":100,"is_preprint":false},{"pmid":"15919372","id":"PMC_15919372","title":"The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells.","date":"2005","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15919372","citation_count":98,"is_preprint":false},{"pmid":"22994411","id":"PMC_22994411","title":"Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure.","date":"2012","source":"Journal of drug targeting","url":"https://pubmed.ncbi.nlm.nih.gov/22994411","citation_count":94,"is_preprint":false},{"pmid":"31875850","id":"PMC_31875850","title":"A GPR174-CCL21 module imparts sexual dimorphism to humoral immunity.","date":"2019","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/31875850","citation_count":92,"is_preprint":false},{"pmid":"29263302","id":"PMC_29263302","title":"Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo.","date":"2017","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/29263302","citation_count":91,"is_preprint":false},{"pmid":"27118869","id":"PMC_27118869","title":"SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms.","date":"2016","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/27118869","citation_count":90,"is_preprint":false},{"pmid":"32017846","id":"PMC_32017846","title":"CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32017846","citation_count":86,"is_preprint":false},{"pmid":"32386596","id":"PMC_32386596","title":"Targeted Degradation of SLC Transporters Reveals Amenability of Multi-Pass Transmembrane Proteins to Ligand-Induced Proteolysis.","date":"2020","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/32386596","citation_count":81,"is_preprint":false},{"pmid":"32340161","id":"PMC_32340161","title":"The Role of CCL21/CCR7 Chemokine Axis in Breast Cancer Progression.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32340161","citation_count":79,"is_preprint":false},{"pmid":"20201039","id":"PMC_20201039","title":"CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19.","date":"2010","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20201039","citation_count":78,"is_preprint":false},{"pmid":"31571165","id":"PMC_31571165","title":"SLC Family Transporters.","date":"2019","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/31571165","citation_count":75,"is_preprint":false},{"pmid":"19454681","id":"PMC_19454681","title":"CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19454681","citation_count":75,"is_preprint":false},{"pmid":"10222066","id":"PMC_10222066","title":"CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors.","date":"1999","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10222066","citation_count":72,"is_preprint":false},{"pmid":"19405996","id":"PMC_19405996","title":"RT-PCR analysis of ABC, SLC and SLCO drug transporters in human lung epithelial cell models.","date":"2009","source":"The Journal of pharmacy and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19405996","citation_count":70,"is_preprint":false},{"pmid":"12740040","id":"PMC_12740040","title":"SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10.","date":"2003","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12740040","citation_count":66,"is_preprint":false},{"pmid":"22392503","id":"PMC_22392503","title":"Role of the CCL21 and CCR7 pathways in rheumatoid arthritis angiogenesis.","date":"2012","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/22392503","citation_count":63,"is_preprint":false},{"pmid":"25147499","id":"PMC_25147499","title":"Neuronal CC chemokines: the distinct roles of CCL21 and CCL2 in neuropathic pain.","date":"2014","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25147499","citation_count":62,"is_preprint":false},{"pmid":"37355450","id":"PMC_37355450","title":"Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.","date":"2023","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37355450","citation_count":60,"is_preprint":false},{"pmid":"32829146","id":"PMC_32829146","title":"CCL21-loaded 3D hydrogels for T cell expansion and differentiation.","date":"2020","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/32829146","citation_count":60,"is_preprint":false},{"pmid":"31189097","id":"PMC_31189097","title":"The RNA-Binding Protein YBX3 Controls Amino Acid Levels by Regulating SLC mRNA Abundance.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31189097","citation_count":60,"is_preprint":false},{"pmid":"34971415","id":"PMC_34971415","title":"The role of SLC transporters for brain health and disease.","date":"2021","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/34971415","citation_count":60,"is_preprint":false},{"pmid":"19451552","id":"PMC_19451552","title":"CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19451552","citation_count":58,"is_preprint":false},{"pmid":"18697841","id":"PMC_18697841","title":"Expression, transport, and axonal sorting of neuronal CCL21 in large dense-core vesicles.","date":"2008","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/18697841","citation_count":53,"is_preprint":false},{"pmid":"10496316","id":"PMC_10496316","title":"SLC/exodus2/6Ckine/TCA4 induces chemotaxis of hematopoietic progenitor cells: differential activity of ligands of CCR7, CXCR3, or CXCR4 in chemotaxis vs. suppression of progenitor proliferation.","date":"1999","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/10496316","citation_count":53,"is_preprint":false},{"pmid":"26667143","id":"PMC_26667143","title":"CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1.","date":"2015","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/26667143","citation_count":52,"is_preprint":false},{"pmid":"21865343","id":"PMC_21865343","title":"ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21865343","citation_count":52,"is_preprint":false},{"pmid":"25798926","id":"PMC_25798926","title":"CCL21/CCR7 enhances the proliferation, migration, and invasion of human bladder cancer T24 cells.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25798926","citation_count":51,"is_preprint":false},{"pmid":"27144525","id":"PMC_27144525","title":"Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27144525","citation_count":50,"is_preprint":false},{"pmid":"12393410","id":"PMC_12393410","title":"Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12393410","citation_count":49,"is_preprint":false},{"pmid":"22438908","id":"PMC_22438908","title":"CCL21/CCR7 prevents apoptosis via the ERK pathway in human non-small cell lung cancer cells.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22438908","citation_count":47,"is_preprint":false},{"pmid":"12065729","id":"PMC_12065729","title":"Low-molecular-weight heparins inhibit CCL21-induced T cell adhesion and migration.","date":"2002","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/12065729","citation_count":46,"is_preprint":false},{"pmid":"17273764","id":"PMC_17273764","title":"CCL21 induces extensive intratumoral immune cell infiltration and specific anti-tumor cellular immunity.","date":"2007","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17273764","citation_count":43,"is_preprint":false},{"pmid":"27057280","id":"PMC_27057280","title":"CCL21 Facilitates Chemoresistance and Cancer Stem Cell-Like Properties of Colorectal Cancer Cells through AKT/GSK-3β/Snail Signals.","date":"2015","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/27057280","citation_count":41,"is_preprint":false},{"pmid":"16675330","id":"PMC_16675330","title":"Role of CCL21 and CCL19 in allergic inflammation in the ovalbumin-specific murine asthmatic model.","date":"2006","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16675330","citation_count":41,"is_preprint":false},{"pmid":"31125713","id":"PMC_31125713","title":"Nonionic surfactants modulate the transport activity of ATP-binding cassette (ABC) transporters and solute carriers (SLC): Relevance to oral drug absorption.","date":"2019","source":"International journal of pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/31125713","citation_count":40,"is_preprint":false},{"pmid":"36774347","id":"PMC_36774347","title":"Distinct tissue niches direct lung immunopathology via CCL18 and CCL21 in severe COVID-19.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36774347","citation_count":39,"is_preprint":false},{"pmid":"20889506","id":"PMC_20889506","title":"CCR7/CCL21 migration on fibronectin is mediated by phospholipase Cgamma1 and ERK1/2 in primary T lymphocytes.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20889506","citation_count":35,"is_preprint":false},{"pmid":"32499193","id":"PMC_32499193","title":"The pathogenic importance of CCL21 and CCR7 in rheumatoid arthritis.","date":"2020","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/32499193","citation_count":33,"is_preprint":false},{"pmid":"33875601","id":"PMC_33875601","title":"Scavenging of soluble and immobilized CCL21 by ACKR4 regulates peripheral dendritic cell emigration.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33875601","citation_count":33,"is_preprint":false},{"pmid":"18802011","id":"PMC_18802011","title":"Anti-inflammatory effects of an inflammatory chemokine: CCL2 inhibits lymphocyte homing by modulation of CCL21-triggered integrin-mediated adhesions.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18802011","citation_count":33,"is_preprint":false},{"pmid":"34404433","id":"PMC_34404433","title":"Urinary small extracellular vesicles derived CCL21 mRNA as biomarker linked with pathogenesis for diabetic nephropathy.","date":"2021","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34404433","citation_count":33,"is_preprint":false},{"pmid":"37397501","id":"PMC_37397501","title":"In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity.","date":"2023","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37397501","citation_count":33,"is_preprint":false},{"pmid":"31494219","id":"PMC_31494219","title":"The effects of CCL3, CCL4, CCL19 and CCL21 as molecular adjuvants on the immune response to VAA DNA vaccine in flounder (Paralichthys olivaceus).","date":"2019","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31494219","citation_count":33,"is_preprint":false},{"pmid":"26504105","id":"PMC_26504105","title":"Differential ligand-signaling network of CCL19/CCL21-CCR7 system.","date":"2015","source":"Database : the journal of biological databases and curation","url":"https://pubmed.ncbi.nlm.nih.gov/26504105","citation_count":32,"is_preprint":false},{"pmid":"21997231","id":"PMC_21997231","title":"CCL21 (SLC) improves tumor protection by a DNA vaccine in a Her2/neu mouse tumor model.","date":"2011","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/21997231","citation_count":31,"is_preprint":false},{"pmid":"32289156","id":"PMC_32289156","title":"ACKR4 restrains antitumor immunity by regulating CCL21.","date":"2020","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32289156","citation_count":31,"is_preprint":false},{"pmid":"28062543","id":"PMC_28062543","title":"Multiple SLC and ABC Transporters Contribute to the Placental Transfer of Entecavir.","date":"2017","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/28062543","citation_count":30,"is_preprint":false},{"pmid":"23643685","id":"PMC_23643685","title":"Dichotomy of CCL21 and CXCR3 in nerve injury-evoked and autoimmunity-evoked hyperalgesia.","date":"2013","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/23643685","citation_count":29,"is_preprint":false},{"pmid":"27471394","id":"PMC_27471394","title":"Decreased expression of SLC 39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancer.","date":"2016","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/27471394","citation_count":29,"is_preprint":false},{"pmid":"34797406","id":"PMC_34797406","title":"SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population.","date":"2021","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34797406","citation_count":28,"is_preprint":false},{"pmid":"29784760","id":"PMC_29784760","title":"Formation of the Intrathymic Dendritic Cell Pool Requires CCL21-Mediated Recruitment of CCR7+ Progenitors to the Thymus.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/29784760","citation_count":27,"is_preprint":false},{"pmid":"25473269","id":"PMC_25473269","title":"CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions.","date":"2014","source":"Drug design, development and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25473269","citation_count":27,"is_preprint":false},{"pmid":"19401230","id":"PMC_19401230","title":"CCL21-induced calcium transients and proliferation in primary mouse astrocytes: CXCR3-dependent and independent responses.","date":"2009","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/19401230","citation_count":27,"is_preprint":false},{"pmid":"37730274","id":"PMC_37730274","title":"CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity.","date":"2023","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37730274","citation_count":26,"is_preprint":false},{"pmid":"35644529","id":"PMC_35644529","title":"Transcriptional Regulation of Solute Carrier (SLC) Drug Transporters.","date":"2022","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/35644529","citation_count":26,"is_preprint":false},{"pmid":"25862123","id":"PMC_25862123","title":"Polarized location of SLC and ABC drug transporters in monolayer-cultured human hepatocytes.","date":"2015","source":"Toxicology in vitro : an international journal published in association with BIBRA","url":"https://pubmed.ncbi.nlm.nih.gov/25862123","citation_count":26,"is_preprint":false},{"pmid":"30518137","id":"PMC_30518137","title":"Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30518137","citation_count":25,"is_preprint":false},{"pmid":"34871842","id":"PMC_34871842","title":"Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors.","date":"2021","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34871842","citation_count":25,"is_preprint":false},{"pmid":"16973962","id":"PMC_16973962","title":"Chemokines CCL19 and CCL21 promote activation-induced cell death of antigen-responding T cells.","date":"2006","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16973962","citation_count":25,"is_preprint":false},{"pmid":"33749483","id":"PMC_33749483","title":"Renal and non-renal response of ABC and SLC transporters in chronic kidney disease.","date":"2021","source":"Expert opinion on drug metabolism & toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/33749483","citation_count":23,"is_preprint":false},{"pmid":"24838092","id":"PMC_24838092","title":"Enhanced antitumor immunity is elicited by adenovirus-mediated gene transfer of CCL21 and IL-15 in murine colon carcinomas.","date":"2014","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24838092","citation_count":23,"is_preprint":false},{"pmid":"26393504","id":"PMC_26393504","title":"Anti-CCL21 antibody attenuates infarct size and improves cardiac remodeling after myocardial infarction.","date":"2015","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26393504","citation_count":23,"is_preprint":false},{"pmid":"24237220","id":"PMC_24237220","title":"CCL21 and IFNγ recruit and activate tumor specific T cells in 3D scaffold model of breast cancer.","date":"2014","source":"Anti-cancer agents in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24237220","citation_count":23,"is_preprint":false},{"pmid":"32276560","id":"PMC_32276560","title":"Role of SLC transporters in toxicity induced by anticancer drugs.","date":"2020","source":"Expert opinion on drug metabolism & toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/32276560","citation_count":22,"is_preprint":false},{"pmid":"36776327","id":"PMC_36776327","title":"SLC-0111, an inhibitor of carbonic anhydrase IX, attenuates hepatoblastoma cell viability and migration.","date":"2023","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36776327","citation_count":22,"is_preprint":false},{"pmid":"22619482","id":"PMC_22619482","title":"oxLDL downregulates the dendritic cell homing factors CCR7 and CCL21.","date":"2012","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/22619482","citation_count":22,"is_preprint":false},{"pmid":"14667884","id":"PMC_14667884","title":"Fluctuation of 6Ckine expression in human endometrium during the menstrual cycle.","date":"2003","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/14667884","citation_count":21,"is_preprint":false},{"pmid":"11739157","id":"PMC_11739157","title":"Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migration.","date":"2001","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11739157","citation_count":21,"is_preprint":false},{"pmid":"25620669","id":"PMC_25620669","title":"SAMP1/YitFc mice develop ileitis via loss of CCL21 and defects in dendritic cell migration.","date":"2015","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/25620669","citation_count":21,"is_preprint":false},{"pmid":"29768676","id":"PMC_29768676","title":"CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells.","date":"2018","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/29768676","citation_count":21,"is_preprint":false},{"pmid":"27044799","id":"PMC_27044799","title":"Kidney versus Liver Specification of SLC and ABC Drug Transporters, Tight Junction Molecules, and Biomarkers.","date":"2016","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/27044799","citation_count":21,"is_preprint":false},{"pmid":"33570638","id":"PMC_33570638","title":"Medullary stromal cells synergize their production and capture of CCL21 for T-cell emigration from neonatal mouse thymus.","date":"2021","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/33570638","citation_count":21,"is_preprint":false},{"pmid":"15569314","id":"PMC_15569314","title":"Binding of the chemokine SLC/CCL21 to its receptor CCR7 increases adhesive properties of human mesangial cells.","date":"2004","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/15569314","citation_count":21,"is_preprint":false},{"pmid":"30744443","id":"PMC_30744443","title":"Unraveling 'The Cancer Genome Atlas' information on the role of SLC transporters in anticancer drug uptake.","date":"2019","source":"Expert review of clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30744443","citation_count":21,"is_preprint":false},{"pmid":"25260647","id":"PMC_25260647","title":"Increased CCL19 and CCL21 levels promote fibroblast ossification in ankylosing spondylitis hip ligament tissue.","date":"2014","source":"BMC musculoskeletal disorders","url":"https://pubmed.ncbi.nlm.nih.gov/25260647","citation_count":20,"is_preprint":false},{"pmid":"28841151","id":"PMC_28841151","title":"CCR7 Sulfotyrosine Enhances CCL21 Binding.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28841151","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50157,"output_tokens":8749,"usd":0.140853},"stage2":{"model":"claude-opus-4-6","input_tokens":12601,"output_tokens":4299,"usd":0.25572},"total_usd":0.396573,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"CCL21 (TCA-4/SLC/6Ckine) is constitutively presented on the luminal surface of high endothelial venules (HEVs) in peripheral lymph nodes, where it activates LFA-1 on rolling T cells via CCR7 (a Gαi-linked receptor), triggering firm adhesion; CCL21 delivered via afferent lymph to draining PLNs was sufficient to restore LFA-1-mediated T cell arrest in plt/plt HEVs that lack endogenous CCL21.\",\n      \"method\": \"Intravital microscopy of murine PLNs with adoptively transferred GFP+ T cells; CCR7 desensitization; intracutaneous injection of CCL21 into plt/plt mice\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo functional rescue experiment with multiple orthogonal approaches (desensitization, reconstitution, imaging)\",\n      \"pmids\": [\"10620605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The CC chemokine 6Ckine (CCL21) binds and activates the CXC chemokine receptor CXCR3 in addition to CCR7, inducing calcium flux in CXCR3-transfected cells; CCL21 also displays angiostatic properties similar to other CXCR3 ligands.\",\n      \"method\": \"Calcium flux assay in mouse CXCR3-transfected cells screened against a panel of chemokines; Matrigel angiostasis assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro receptor binding/activation assay with functional readout\",\n      \"pmids\": [\"9653165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Mouse 6Ckine (CCL21) is encoded by two distinct genes; one gene expressed in lymphoid organs is deleted in plt/plt mice, explaining the absence of CCL21 in lymphoid tissues of those mice and their T cell homing defect.\",\n      \"method\": \"Genomic analysis, gene deletion mapping in plt/plt mice\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct genetic characterization with functional consequence (loss of lymphoid CCL21 expression)\",\n      \"pmids\": [\"10523616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Ectopic expression of CCL21 (TCA4/SLC) in pancreatic islets is sufficient to trigger lymphoid neogenesis, recruiting naive T cells and dendritic cells (which express CCR7) and inducing organized lymphoid tissue with high endothelial venules and stromal reticulum; B cell recruitment required T cells/DCs as intermediaries.\",\n      \"method\": \"Transgenic mouse model with islet-specific CCL21 expression; backcross to RAG-1 and Ikaros knockout mice\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic gain-of-function with defined cellular and structural readouts, replicated in multiple genetic backgrounds\",\n      \"pmids\": [\"10754285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Mouse CCL21/SLC exerts antitumor effects through two mechanisms: (1) angiostasis via interaction with CXCR3, and (2) induction of CD8+ T cell- and NK cell-mediated tumor-specific immunity; tumor-infiltrating DCs retained an immature phenotype.\",\n      \"method\": \"Tumor cell transduction with CCL21 cDNA; in vivo Matrigel assay for angiostasis; antibody depletion of CD8+ T cells and NK cells; immunohistochemistry\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vivo mechanistic approaches (angiostasis assay, depletion experiments, immunophenotyping)\",\n      \"pmids\": [\"10925282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CCL21 is involved in recruitment of T-cell precursors to the fetal thymus; neutralizing antibodies against CCL21 (and CCL25) markedly diminish fetal thymus colonization, and CCL21-deficient plt/plt mice show partial defects in this colonization.\",\n      \"method\": \"Time-lapse visualization culture of fetal thymus colonization; neutralizing antibody blockade; plt/plt mice\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional reconstitution assay with antibody neutralization and genetic knockout, replicated with multiple approaches\",\n      \"pmids\": [\"15358618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Neuronal CCL21 is sorted into large dense-core vesicles (the regulated secretory pathway) and preferentially transported into axons, establishing a mechanism for directed neuron-to-microglia communication from injured neurons.\",\n      \"method\": \"Live-cell imaging of CCL21-vesicle trafficking; subcellular fractionation; fluorescence microscopy of axonal vs. dendritic sorting\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct live-cell imaging and subcellular fractionation with functional interpretation\",\n      \"pmids\": [\"18697841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CCL21 expressed in injured primary sensory neurons is transported to central terminals in the dorsal horn, where it up-regulates microglial P2X4 receptor expression to initiate neuropathic pain (tactile allodynia); CCL21-deficient mice do not develop allodynia or upregulate P2X4, and intrathecal CCL21 restores allodynia in CCL21-deficient nerve-injured mice in a P2X4-dependent manner.\",\n      \"method\": \"CCL21 knockout mice, intrathecal antibody blockade, intrathecal CCL21 injection, in vitro CCL21 application to microglia, P2X4 receptor expression assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function KO with rescue experiment and mechanistic pathway identification (P2X4 dependence)\",\n      \"pmids\": [\"21441897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CCL21 costimulates CD4+ T cell activation via CCR7 through a DOCK2/Rac-dependent pathway: CCL21 during early TCR signaling increases Ras- and Rac-GTP formation, phosphorylation of Akt, MEK, and ERK (but not p38 or JNK), lowering the T cell activation threshold; DOCK2 deficiency impairs CCL21 costimulation and Rac-GTP formation.\",\n      \"method\": \"Primary TCR-transgenic CD4+ T cells; kinase-dead PI3Kδ and PI3Kγ-deficient mice; DOCK2-deficient mice; GTPase activation assays; lymph node slice live imaging\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic KO models with biochemical pathway dissection\",\n      \"pmids\": [\"19451552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CCR7/CCL21-mediated T lymphocyte migration on fibronectin requires rapid, transient ERK1/2 phosphorylation (within 2 min) downstream of PLCγ1; PLCγ1 shRNA knockdown reduces ERK1/2 phosphorylation and CCR7-mediated migration, and ERK1/2 inhibition reduces PLCγ1 phosphorylation, indicating a feedback loop between ERK1/2 and PLCγ1.\",\n      \"method\": \"shRNA knockdown of PLCγ1; pharmacological inhibition of MEK (U0126) and PLC (U73122); phosphorylation assays; migration assays on fibronectin\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches (genetic KD + pharmacological inhibition) with defined signaling pathway\",\n      \"pmids\": [\"20889506\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CCL21 alone (without CCL19) is sufficient to mediate DC migration from skin, DC maturation, and efficient T cell priming in vivo; CCL19 is redundant for these processes, as demonstrated in CCL19-deficient mice expressing various levels of CCL21.\",\n      \"method\": \"CCL19-deficient mice with varying CCL21 expression levels; flow cytometry of DC frequencies and localization; T cell priming assays\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with dose-response analysis across multiple CCL21 levels\",\n      \"pmids\": [\"20201039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GPR174, an X-chromosome-encoded GPCR, is identified as a receptor for CCL21; CCL21 triggers GPR174-mediated calcium flux and preferentially induces migration of male B cells; GPR174 associates more strongly with Gαi protein in male than female B cells, and this sex difference is regulated by testosterone.\",\n      \"method\": \"Biochemical fractionation of conditioned media; calcium flux assay; B cell migration assay; Co-IP of GPR174-Gαi; orchidectomy and testosterone treatment; GPR174 conditional deletion\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical identification of CCL21 as GPR174 ligand with functional validation (calcium flux, migration), multiple orthogonal methods including genetic deletion and hormonal manipulation\",\n      \"pmids\": [\"31875850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ACKR4 scavenges two forms of CCL21 in barrier tissues — full-length immobilized and cleaved soluble CCL21 — to establish functional extracellular CCL21 gradients; without ACKR4, CCL21 gradients are saturated and non-functional, DCs cannot home to lymphatic vessels, and excess soluble CCL21 from peripheral tissues floods downstream lymph nodes.\",\n      \"method\": \"ACKR4-deficient mice; quantification of CCL21 forms in skin and LNs; DC migration assays; flow cytometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with biochemical characterization of two CCL21 forms and mechanistic explanation of gradient regulation\",\n      \"pmids\": [\"33875601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Low-molecular-weight heparins (and glycosaminoglycans) strongly inhibit CCL21-induced T cell adhesion and chemotaxis; enzymatic cleavage of GAGs abrogates this inhibition, revealing that heparin-like GAGs regulate CCL21 function by modulating its local availability.\",\n      \"method\": \"T cell adhesion and chemotaxis assays with heparinase treatment and low-molecular-weight heparins\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct in vitro functional assays with enzymatic and pharmacological tools; single lab\",\n      \"pmids\": [\"12065729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CCL21 expression is induced in endothelial cells during T cell autoimmune skin diseases, where its receptor CCR7 is expressed on infiltrating memory T cells (CD45Ro+), suggesting a role for CCL21/CCR7 in mediating T cell infiltration at sites of autoimmune inflammation.\",\n      \"method\": \"Immunohistology of T-cell autoimmune skin disease specimens\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — immunohistology only, no functional experiment\",\n      \"pmids\": [\"12393410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CCL21 activates CCR7 on hepatic stellate cells (HSCs), triggering ERK, Akt, and NF-κB signaling pathways, stimulating HSC migration and wound healing in vitro, and inducing pro-inflammatory gene expression, implicating CCL21/CCR7 in hepatic fibrogenesis.\",\n      \"method\": \"In vitro HSC migration assay; wound healing assay; Western blot for ERK, Akt, NF-κB; CCR7 expression by flow cytometry\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro functional assays with multiple signaling pathway readouts; single lab\",\n      \"pmids\": [\"14517790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CCL21 (SLC/CCL21) binding to CCR7 on human mesangial cells enhances their adhesion to fibronectin in a time- and concentration-dependent manner, activates integrin-linked kinase (ILK) leading to phosphorylation of GSK-3 and PKB/Akt, and causes F-actin rearrangements with membrane ruffling.\",\n      \"method\": \"Adhesion assays; mechanical detachment assays; ILK activity assay; phalloidin immunofluorescence for F-actin\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays with defined signaling readouts; single lab\",\n      \"pmids\": [\"15569314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CCL21/CCR7 signaling promotes the migration of CCR7+ fibrocytes into the kidney in response to CCL21+ vessels during renal fibrosis; blockade of CCL21/CCR7 (anti-CCL21 antibodies or CCR7-null mice) reduced fibrocyte infiltration, renal fibrosis, TGF-β1 and collagen I transcripts, and macrophage recruitment.\",\n      \"method\": \"Unilateral ureteral obstruction mouse model; anti-CCL21 antibody blockade; CCR7-null mice; immunohistochemistry; qRT-PCR\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — both pharmacological neutralization and genetic knockout with consistent phenotype; replicated across two approaches\",\n      \"pmids\": [\"16966615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CCR7-CCL19/CCL21 pathway is required for antigen-bearing dendritic cells to migrate from sublingual mucosa to cervical lymph nodes and prime antigen-specific T and B cell responses; depletion of CD11c+ cells or CCR7 deficiency abolished T cell proliferation after sublingual vaccination.\",\n      \"method\": \"CCR7-/- mice; CD11c depletion; reconstitution with OVA-specific CD4+/CD8+ T cells; flow cytometry; antibody measurement\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO and cell depletion with defined functional readouts\",\n      \"pmids\": [\"19454681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CCL21 (but not CCL19) induces human microvascular endothelial cell (HMVEC) migration and tube formation via CCR7 through the PI3K pathway; CCL21 promotes blood vessel growth in Matrigel plugs in vivo at concentrations found in RA joints, identifying CCL21 as a direct mediator of angiogenesis.\",\n      \"method\": \"HMVEC chemotaxis assays; tube formation assays; PI3K/ERK/JNK pathway inhibitors; in vivo Matrigel plug assay; CCR7 neutralization\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro assays plus in vivo Matrigel with receptor neutralization and pathway inhibition\",\n      \"pmids\": [\"22392503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CCL21/CCR7 activation prevents apoptosis in non-small cell lung cancer cells by upregulating Bcl-2 and downregulating Bax and caspase-3 via the ERK pathway; co-immunoprecipitation confirmed interaction between p-ERK and Bcl-2/Bax/caspase-3.\",\n      \"method\": \"Flow cytometry apoptosis assay; Western blot and qRT-PCR; MEK inhibitor PD98059; CCR7 siRNA knockdown; co-immunoprecipitation\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KD + pharmacological inhibition + Co-IP with defined pathway; single lab\",\n      \"pmids\": [\"22438908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CCL21/CCR7 axis promotes breast cancer-associated lymphangiogenesis by upregulating VEGF-C secretion via AKT signaling; in vivo, CCR7/CCL21-expressing breast cancer cells promote lymph-vascular recruitment; in vitro, CCL21/CCR7 drives LEC proliferation, migration, and tube formation.\",\n      \"method\": \"In vivo orthotopic nude mouse model with CCR7/CCL21 gene-manipulated cells; in vitro LEC functional assays; Western blot for AKT; qRT-PCR; IHC\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic manipulation plus in vitro mechanistic assays; single lab\",\n      \"pmids\": [\"25744065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Formation of intrathymic dendritic cell type 1 (cDC1) pool requires CCR7-CCL21Ser interactions to guide migration of CCR7+ cDC progenitors to the thymus; mice lacking CCR7 or CCL21Ser (but not CCL19) show selective reduction in thymic cDC1.\",\n      \"method\": \"CCR7-/-, CCL21Ser-/-, and CCL19-/- mice; flow cytometry of thymic DC subsets; progenitor identification\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic KO models with ligand-specific dissection of requirements\",\n      \"pmids\": [\"29784760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CCL21 neonatal thymus emigration is mediated by CCL21 (not CCL19); CCL21 gene expression occurs in medullary epithelial subsets while CCL21 protein is captured and presented at sites of thymic exit by integrin α7+ pericytes and CD34+ adventitial cells via heparan sulfate-dependent interaction with CCL21's C-terminal extension; CCL19 (which lacks this domain) is not captured by thymic stroma.\",\n      \"method\": \"CCL21- and CCL19-deficient mice; Ccl21 gene expression mapping; CCL21 protein distribution analysis; cell-type fractionation; heparan sulfate dependency assays\",\n      \"journal\": \"Blood advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with mechanistic dissection of protein capture via C-terminal domain and heparan sulfate; orthogonal approaches\",\n      \"pmids\": [\"33570638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CCR7 sulfotyrosine (sY) at positions Y8 and Y17 enhances CCL21 binding affinity; sY8-containing peptides bind near the CCL21 α-helix while sY17-containing peptides bind near the N-loop and β3-strand; phosphotyrosine also enhances binding but less than sulfotyrosine.\",\n      \"method\": \"Protein NMR spectroscopy of CCL21 with CCR7 N-terminal peptides containing Tyr, phosphoTyr, or sulfoTyr\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural NMR with defined binding site mapping\",\n      \"pmids\": [\"28841151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Fluorescently tagged CCL21-mRFP retains functional activity and can be used to visualize and quantify CCL21 gradients in real time; CCL21-mRFP is internalized by CCR7-expressing cells and scavenged by ACKR4, enabling spatiotemporal study of receptor trafficking and chemokine gradient formation.\",\n      \"method\": \"Fusion protein production; receptor trafficking assays; chemokine scavenging assays; live-cell gradient visualization\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional validation of tagged chemokine with receptor trafficking and scavenging readouts; single lab\",\n      \"pmids\": [\"30518137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CCL21's C-terminal extension mediates its enhanced binding to glycosaminoglycans (GAGs) on dendritic cell surfaces; transfer of CCL21-tail to CCL19 increases GAG binding but negatively affects cAMP signaling potency; removal of CCL21 tail (CCL21tailless) increases cAMP signaling compared to full-length CCL21, indicating the C-terminal tail autoinhibits CCR7 signaling.\",\n      \"method\": \"CCL21/CCL19 chimeric proteins; calcium release assays; cAMP assays in CHO cells; DC chemotaxis assays; CCR7 internalization assays\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — domain-swap mutagenesis with multiple functional readouts (GAG binding, cAMP, calcium, chemotaxis, receptor internalization)\",\n      \"pmids\": [\"29768676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CCL21 promotes migration of pancreatic cancer cells toward sensory neurons via CCR7 expressed on cancer cells; neutralization of CCL21 or CCR7 in mice with orthotopic tumors reduces nociceptive hypersensitivity and nerve fiber hypertrophy without affecting tumor immune infiltration.\",\n      \"method\": \"RNA interference screen; PDAC cell migration assays; neutralizing antibody treatment in orthotopic tumor model; abdominal mechanical hypersensitivity testing; histology\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — unbiased RNAi screen followed by functional validation in vivo with neutralizing antibodies; multiple readouts\",\n      \"pmids\": [\"32330476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CCL21/CCR7 interaction activates JAK2/STAT3 signaling in oral squamous cell carcinoma cells, promoting EMT and cancer stem cell properties (CD133, CD44, BMI1, ALDH1A1, OCT4 upregulation); JAK2/STAT3 inhibition suppresses these CCL21-induced effects.\",\n      \"method\": \"Exogenous CCL21 stimulation; CCR7 knockdown and overexpression; JAK2/STAT3 inhibitor treatment; Western blot; migration/invasion/tumorsphere assays\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic manipulation plus pharmacological inhibition with pathway identification; single lab\",\n      \"pmids\": [\"32017846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CCL21 induces calcium transients in primary mouse astrocytes via CXCR3 at low concentrations; at high CCL21 concentrations (10⁻⁷ M), calcium transients persist in CXCR3-deficient astrocytes, and CCL21-induced proliferation is not impaired in CXCR3-deficient astrocytes, indicating CCL21 activates an additional, as-yet unidentified receptor on astrocytes.\",\n      \"method\": \"Calcium imaging; CXCR3-deficient astrocytes; CXCL10 comparison; proliferation assays\",\n      \"journal\": \"Brain, behavior, and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with pharmacological comparison; identifies additional receptor but does not identify it\",\n      \"pmids\": [\"19401230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CCL21/CCL19 produced in secondary lymphoid organs promote activation-induced cell death (AICD) of antigen-responding CD4+ T cells during the clonal contraction phase, partly by enhancing Fas ligand expression; plt/plt mice lacking CCL21/CCL19 show prolonged CD4+ T cell responses without increased apoptosis.\",\n      \"method\": \"plt/plt mice immunized with OVA/CFA; in vivo tracking of OVA-responding CD4+ T cells; in vitro AICD assay with CCL19/CCL21; Fas ligand expression analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with in vitro mechanistic follow-up (FasL expression); consistent in vivo and in vitro results\",\n      \"pmids\": [\"16973962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ZAP-70 expression in CLL B cells enhances CCR7 upregulation after IgM stimulation via the ERK1/2 (MAPK) pathway, increasing CCR7 signaling and migration toward CCL21; ERK1/2 inhibition impairs CCR7 upregulation and CCL21-directed migration.\",\n      \"method\": \"ZAP-70-transfected Ramos cell line; ERK1/2, Akt, Syk phosphorylation assays; CCR7 expression by flow cytometry; migration assay toward CCL21; primary CLL samples\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — stable transfection with pathway inhibition; validated in primary CLL samples\",\n      \"pmids\": [\"21865343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CCL21-CCR7 promotes lymph node metastasis of esophageal squamous cell carcinoma by upregulating MUC1 via ERK1/2-mediated phosphorylation of Sp1, which increases Sp1 binding to the MUC1 promoter at -99/-90; Akt is also activated but is not responsible for MUC1 transcriptional upregulation.\",\n      \"method\": \"Transwell migration/invasion assays; luciferase reporter assay; Western blot for ERK, Akt, Sp1; ChIP for Sp1 binding to MUC1 promoter; MUC1 knockdown\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple mechanistic assays including ChIP; single lab\",\n      \"pmids\": [\"26667143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CCL21 facilitates chemoresistance and cancer stem cell properties in colorectal cancer via the AKT/GSK-3β/Snail signaling pathway, upregulating P-glycoprotein and stem cell markers (Bmi-1, Nanog, OCT-4) at the post-transcriptional level; PI3K/Akt inhibitor (LY294002) abolishes these effects.\",\n      \"method\": \"CCL21 treatment of HCT116 cells; Western blot; PI3K inhibitor LY294002; mammosphere formation assay; cell survival assay\",\n      \"journal\": \"Oxidative medicine and cellular longevity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological inhibition with multiple readouts; single lab\",\n      \"pmids\": [\"27057280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CCL21 (via CCR7/CCL21 axis, assessed in plt/plt mice) is required for nerve injury-evoked tactile allodynia but not autoimmunity-evoked (EAE) hyperalgesia; conversely, CXCR3 mediates EAE-evoked hyperalgesia but not traumatic nerve injury pain, demonstrating dichotomous roles for CCL21 ligands in different neuropathic pain contexts.\",\n      \"method\": \"plt/plt mice; CXCR3-/- mice; double knockout mice; sciatic nerve injury; EAE model; behavioral pain testing; spinal cord immunophenotyping\",\n      \"journal\": \"Brain, behavior, and immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic KO models with epistasis analysis; two distinct pain models\",\n      \"pmids\": [\"23643685\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ACKR4 on non-hematopoietic cells controls intratumoral CCL21 abundance, which in turn regulates CD103+ dendritic cell retention in tumors and CD8+ T cell accumulation; in the absence of ACKR4, increased intratumoral CCL21 promotes anti-tumor immunity and inhibits tumor growth.\",\n      \"method\": \"ACKR4-deficient mice; bone marrow chimeras to define non-hematopoietic ACKR4 requirement; flow cytometry of tumor-infiltrating leukocytes; CCL21 quantification in tumors\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with bone marrow chimeras defining cell-specific mechanism; CCL21 quantification\",\n      \"pmids\": [\"32289156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In severe COVID-19, CCL21 overexpression in activated adventitial niches is associated with endothelial-to-mesenchymal transition and tissue fibrosis, and links to accumulation of CCR7-expressing exhausted T cells that form lymphoid aggregates and ectopic lymphoid structures.\",\n      \"method\": \"Advanced imaging; spatial transcriptomics of COVID-19 lung tissue; immunophenotyping\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — spatial transcriptomics and imaging without functional manipulation; association between CCL21 and cellular/structural outcomes\",\n      \"pmids\": [\"36774347\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CCL21 is a constitutively expressed CC chemokine that primarily signals through CCR7 (and also CXCR3 and GPR174) to orchestrate the migration and positioning of naïve T cells, dendritic cells, and NK cells in secondary lymphoid organs via LFA-1 activation and DOCK2/Rac-ERK-dependent pathways; in the nervous system, CCL21 is expressed in injured neurons, packaged into large dense-core vesicles, and transported axonally to the dorsal horn where it upregulates microglial P2X4 receptor expression to initiate neuropathic pain; its C-terminal extension mediates heparan sulfate/GAG-dependent immobilization and gradient formation, which is regulated by ACKR4-mediated scavenging, and CCL21 additionally drives angiogenesis, fibrosis, lymphoid neogenesis, and cancer cell migration via PI3K/AKT, JAK2/STAT3, and ERK signaling cascades downstream of CCR7.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CCL21 is a constitutively expressed CC chemokine that serves as the principal ligand for CCR7 in organizing immune cell trafficking, lymphoid tissue architecture, and neuroimmune communication. Through CCR7, CCL21 activates LFA-1 on rolling T cells to trigger firm adhesion at high endothelial venules, costimulates CD4+ T cell activation via DOCK2/Rac-ERK signaling, promotes dendritic cell migration from peripheral tissues to draining lymph nodes, and drives activation-induced cell death during clonal contraction [PMID:10620605, PMID:19451552, PMID:20201039, PMID:16973962]. CCL21 also signals through CXCR3 to exert angiostatic effects and through GPR174 to regulate sex-biased B cell migration, while its unique C-terminal extension mediates heparan sulfate-dependent immobilization on stromal cells to form functional chemokine gradients shaped by ACKR4-mediated scavenging [PMID:9653165, PMID:31875850, PMID:29768676, PMID:33875601, PMID:33570638]. In the nervous system, neuronal CCL21 is sorted into large dense-core vesicles, transported axonally to the spinal dorsal horn, and upregulates microglial P2X4 receptors to initiate neuropathic pain after nerve injury [PMID:18697841, PMID:21441897].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing that CCL21 signals through a second receptor (CXCR3) in addition to its primary receptor CCR7 expanded its functional repertoire to include angiostatic activity shared with CXC chemokines.\",\n      \"evidence\": \"Calcium flux assay in CXCR3-transfected cells plus Matrigel angiostasis assay\",\n      \"pmids\": [\"9653165\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CXCR3-mediated angiostasis is relevant in vivo in tumor microenvironments was not resolved\", \"Relative contribution of CXCR3 vs. CCR7 signaling in different cell types unclear\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identification of two distinct CCL21 genes in mice, with one deleted in plt/plt mice, provided the genetic basis for the T cell homing defect and established plt/plt as a bona fide CCL21-deficiency model.\",\n      \"evidence\": \"Genomic deletion mapping in plt/plt mice\",\n      \"pmids\": [\"10523616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional difference between the two mouse CCL21 gene products not fully defined\", \"Whether human CCL21 gene regulation parallels the two-gene system was unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"CCL21 was shown to be the critical chemokine presented on HEV luminal surfaces that triggers LFA-1-mediated T cell arrest via CCR7/Gαi signaling, and its ectopic expression sufficed to drive lymphoid neogenesis with organized HEVs and stromal reticulum.\",\n      \"evidence\": \"Intravital microscopy with CCR7 desensitization and plt/plt reconstitution; transgenic islet-specific CCL21 expression in RAG-1 and Ikaros KO backgrounds; tumor transduction with CCL21 cDNA plus antibody depletion experiments\",\n      \"pmids\": [\"10620605\", \"10754285\", \"10925282\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which CCL21 induces HEV differentiation and stromal remodeling not defined\", \"Relative roles of CCL21 vs. CCL19 in lymphoid neogenesis unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrating that glycosaminoglycans regulate CCL21 bioavailability by modulating its local concentration established the importance of GAG interactions for CCL21 gradient function.\",\n      \"evidence\": \"T cell adhesion and chemotaxis assays with heparinase treatment and low-molecular-weight heparins\",\n      \"pmids\": [\"12065729\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific GAG structures involved not identified\", \"In vivo relevance of GAG-mediated CCL21 regulation not demonstrated at this stage\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"CCL21 was shown to participate in fetal thymus colonization by T cell precursors, extending its role from peripheral lymphoid homing to thymic seeding.\",\n      \"evidence\": \"Time-lapse fetal thymus colonization assay with anti-CCL21 neutralization and plt/plt mice\",\n      \"pmids\": [\"15358618\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of CCL21 vs. CCL25 in thymic colonization not fully dissected\", \"Whether CCL21 acts as a chemoattractant or a retention signal for thymic progenitors was unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Two new functional dimensions of CCL21 were established: promotion of renal fibrosis via CCR7+ fibrocyte recruitment, and regulation of T cell clonal contraction through enhancement of Fas ligand-mediated AICD.\",\n      \"evidence\": \"Ureteral obstruction model with anti-CCL21 antibody and CCR7-null mice; plt/plt mice immunized with OVA/CFA with in vitro AICD assays\",\n      \"pmids\": [\"16966615\", \"16973962\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CCL21 directly upregulates FasL on T cells or acts indirectly through DCs not resolved\", \"Contribution of CCL21 vs. CCL19 to AICD not fully separated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Discovery that neuronal CCL21 is sorted into large dense-core vesicles and preferentially transported into axons established a mechanism for directed neuron-to-microglia signaling distinct from its immunological roles.\",\n      \"evidence\": \"Live-cell imaging of CCL21-vesicle trafficking with subcellular fractionation in primary neurons\",\n      \"pmids\": [\"18697841\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The receptor on microglia mediating CCL21 responses in the CNS was not identified at this point\", \"Stimulus for neuronal CCL21 transcriptional induction after injury was unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The intracellular signaling cascade downstream of CCR7/CCL21 in T cells was mapped: DOCK2/Rac activation feeds into ERK/MEK phosphorylation to costimulate TCR signaling, while PLCγ1 and ERK1/2 form a positive feedback loop required for T cell migration on fibronectin.\",\n      \"evidence\": \"DOCK2-deficient, PI3Kδ kinase-dead, and PI3Kγ-deficient primary T cells with GTPase activation assays; PLCγ1 shRNA knockdown with MEK inhibitor treatment in migration assays\",\n      \"pmids\": [\"19451552\", \"20889506\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How DOCK2 is recruited to the CCR7 signaling complex was not defined\", \"Whether the PLCγ1-ERK feedback loop operates in all CCR7-expressing cell types was untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"CCL21 alone was shown to be sufficient for DC migration from skin, DC maturation, and T cell priming, establishing CCL19 as functionally redundant for these processes.\",\n      \"evidence\": \"CCL19-deficient mice with varying CCL21 expression levels; DC frequency and T cell priming assays\",\n      \"pmids\": [\"20201039\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CCL19 has non-redundant roles in other contexts (e.g., T cell zone positioning) remained open\", \"Dose-response relationship for CCL21 in sustaining immune homeostasis not defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The neuronal CCL21 pathway was completed: CCL21 transported to dorsal horn central terminals upregulates microglial P2X4 receptors to initiate neuropathic pain, as CCL21 knockout prevents allodynia and intrathecal CCL21 rescues it in a P2X4-dependent manner.\",\n      \"evidence\": \"CCL21 knockout mice with nerve injury; intrathecal CCL21 injection rescue; P2X4 expression assays on microglia\",\n      \"pmids\": [\"21441897\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The microglial receptor for CCL21 in the CNS that triggers P2X4 upregulation was not identified (neither CCR7 nor CXCR3 was confirmed)\", \"Whether CCL21 acts directly on microglia or through an intermediate cell type was not definitively established\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"CCL21 was shown to be specifically required for nerve injury-evoked but not autoimmune-evoked neuropathic pain, while CXCR3 mediates the latter, demonstrating context-dependent dichotomy among CCL21's receptor pathways in pain.\",\n      \"evidence\": \"plt/plt mice, CXCR3-/- mice, and double knockouts tested in sciatic nerve injury vs. EAE models with behavioral pain testing\",\n      \"pmids\": [\"23643685\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism distinguishing traumatic vs. autoimmune pain pathways downstream of CCL21 undefined\", \"Whether CXCR3 contributes to CCL21-mediated nerve injury pain was not excluded\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Structural NMR revealed that CCR7 sulfotyrosine modifications at Y8 and Y17 enhance CCL21 binding by engaging distinct epitopes near the α-helix and N-loop/β3-strand, providing the first atomic-level view of the CCL21-CCR7 interaction.\",\n      \"evidence\": \"Protein NMR with CCR7 N-terminal peptides containing Tyr, phosphoTyr, or sulfoTyr modifications\",\n      \"pmids\": [\"28841151\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length CCR7 structure in complex with CCL21 not available\", \"Functional consequences of sulfotyrosine modifications on CCR7 signaling in cells not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Domain-swap mutagenesis established that CCL21's C-terminal extension autoinhibits CCR7 cAMP signaling while enhancing GAG binding, explaining how immobilized CCL21 creates haptotactic gradients with attenuated receptor activation; separately, CCL21-Ser was shown to specifically guide cDC1 progenitor migration to the thymus.\",\n      \"evidence\": \"CCL21/CCL19 chimeric proteins with calcium, cAMP, chemotaxis, and receptor internalization assays; CCR7-/-, CCL21Ser-/-, CCL19-/- mice with thymic DC subset analysis\",\n      \"pmids\": [\"29768676\", \"29784760\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for C-terminal tail autoinhibition not resolved\", \"Whether proteolytic removal of the tail is regulated in specific physiological contexts was not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"GPR174 was identified as a third receptor for CCL21, mediating sex-biased B cell migration through testosterone-regulated Gαi coupling, revealing an unexpected layer of CCL21 signaling beyond CCR7 and CXCR3.\",\n      \"evidence\": \"Biochemical fractionation identifying CCL21 as GPR174 ligand; calcium flux; B cell migration; GPR174 conditional deletion; orchidectomy and testosterone treatment\",\n      \"pmids\": [\"31875850\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of GPR174/CCL21 axis in lymphoid organ homeostasis not fully characterized\", \"Whether GPR174 and CCR7 compete for CCL21 or transduce distinct signals on the same cell was unexplored\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Two studies established CCL21 as a functionally bidirectional signal in tumors: ACKR4 scavenging on non-hematopoietic cells limits intratumoral CCL21, restricting CD103+ DC retention and anti-tumor immunity, while CCL21/CCR7 on pancreatic cancer cells promotes perineural invasion and pain.\",\n      \"evidence\": \"ACKR4-deficient mice with bone marrow chimeras and tumor-infiltrating leukocyte analysis; RNAi screen with orthotopic PDAC model and CCL21/CCR7 neutralization\",\n      \"pmids\": [\"32289156\", \"32330476\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether therapeutic CCL21 augmentation in tumors would enhance immunotherapy efficacy was not tested\", \"Mechanism by which CCL21 promotes nerve fiber hypertrophy in PDAC unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The CCL21 gradient-shaping mechanism was defined: ACKR4 scavenges both immobilized and cleaved soluble CCL21 forms, while heparan sulfate on pericytes and adventitial cells captures full-length CCL21 via its C-terminal extension, creating functional gradients for DC and thymocyte migration.\",\n      \"evidence\": \"ACKR4-deficient mice with quantification of two CCL21 forms; CCL21/CCL19-deficient mice with cell-type fractionation and heparan sulfate dependency assays in thymus\",\n      \"pmids\": [\"33875601\", \"33570638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether specific heparan sulfate sulfation patterns determine CCL21 capture efficiency is unknown\", \"Dynamics of CCL21 cleavage (protease identity, regulation) not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The microglial receptor through which CCL21 upregulates P2X4 in the CNS remains unidentified, the structural basis of the CCL21 C-terminal tail autoinhibition is unresolved, and the functional interplay among CCR7, CXCR3, and GPR174 on cells co-expressing these receptors has not been dissected.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"CNS receptor for CCL21 on microglia not identified\", \"No full-length CCR7-CCL21 co-structure available\", \"Signaling crosstalk between CCR7, CXCR3, and GPR174 on co-expressing cells uncharacterized\", \"Protease responsible for C-terminal tail cleavage generating soluble CCL21 not identified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 1, 3, 11]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [13, 23, 26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 12, 23]},\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [13, 23]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 3, 4, 5, 10, 18, 30, 35]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 9, 15, 16, 28]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [6, 7, 34]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5, 22, 23]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [20, 21, 27, 28, 32, 33]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CCR7\",\n      \"CXCR3\",\n      \"GPR174\",\n      \"ACKR4\",\n      \"LFA-1\",\n      \"DOCK2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}